The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia

被引:108
|
作者
Velligan, Dawn I. [1 ]
Diamond, Pamela M. [4 ]
Mintz, Jim [1 ]
Maples, Natalie [1 ]
Li, Xueying [1 ]
Zeber, John [1 ,5 ]
Ereshefsky, Larry [2 ]
Lam, Yui-Wing F. [3 ]
Castillo, Desiree [1 ]
Miller, Alexander L. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78284 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacotherapy Educ & Res, San Antonio, TX 78284 USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78284 USA
[4] Univ Texas Houston, Sch Publ Hlth, Ctr Hlth Promot & Prevent Res, Houston, TX USA
[5] Vet Affairs HSR&D, VERDICT, San Antonio, TX USA
关键词
D O I
10.1093/schbul/sbm111
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Cognitive adaptation training (CAT) is a psychosocial treatment that uses environmental supports such as signs, checklists, alarms, and the organization of belongings to cue and sequence adaptive behaviors in the home. Ninety-five outpatients with schizophrenia (structured clinical interview for diagnosis, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) were randomly assigned to (1) Full-CAT (CAT focused on many aspects of community adaptation including grooming, care of living quarters, leisure skills, social and role performance, and medication adherence), (2) Pharm-CAT (CAT focused only on medication and appointment adherence), or (3) treatment as usual (TAU). Treatment lasted for 9 months, and patients were followed for 6 months after the withdrawal of home visits. Medication adherence (assessed during unannounced, in-home pill counts) and functional outcomes were assessed at 3-month intervals. Results of mixed-effects regression models indicated that both CAT and Pharm-CAT treatments were superior to TAU for improving adherence to prescribed medication (P < .0001). Effects on medication adherence remained significant when home visits were withdrawn. Full-CAT treatment improved functional outcome relative to Pharm-CAT and TAU (P < .0001). However, differences for functional outcome across groups decreased following the withdrawal of home visits and were no longer statistically significant at the 6-month follow-up. Survival time to relapse or significant exacerbation was significantly longer in both CAT and Pharm-CAT in comparison to TAU (.004). Findings indicate that supports targeting medication adherence can improve and maintain this behavior. Comprehensive supports targeting multiple domains of functioning are necessary to improve functional outcomes. Maintenance of gains in functional outcome may require some form of continued intervention.
引用
收藏
页码:483 / 493
页数:11
相关论文
共 50 条
  • [1] ENVIRONMENTAL SUPPORTS AND TECHNICAL ADVANCES IMPROVE ADHERENCE TO MEDICATION IN SCHIZOPHRENIA
    Draper, Meredith Lee
    Velligan, D. I.
    Maples, N. J.
    Ritch, J. L.
    Li, X.
    Miller, L.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 322 - 322
  • [2] Comparing the efficacy of interventions that use environmental supports to improve outcomes in patients with schizophrenia
    Velligan, Dawn I.
    Diamond, Pamela M.
    Maples, Natalie J.
    Mintz, James
    Li, Xueying
    Glahn, David C.
    Miller, Alexander L.
    [J]. SCHIZOPHRENIA RESEARCH, 2008, 102 (1-3) : 312 - 319
  • [3] Holistic Consideration of Patients with Schizophrenia to Improve Medication Adherence and Outcomes
    Lee, Lan-Ting
    Chen, Kao Chin
    Chang, Wei Hung
    Chen, Po See
    Lee, I. Hui
    Yang, Yen Kuang
    [J]. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2015, 13 (02) : 138 - 143
  • [4] Tailored Education To Improve Glaucoma Medication Adherence
    Killeen, O.
    MacKenzie, C.
    Heisler, M.
    Newman-Casey, P.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S280 - S280
  • [5] Interventions to improve medication adherence in schizophrenia
    Zygmunt, A
    Olfson, M
    Boyer, CA
    Mechanic, D
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (10): : 1653 - 1664
  • [6] Environmental supports and outcomes in schizophrenia
    Diamond, P. M.
    Zeber, J.
    Maples, N. J.
    Stutes, D.
    Glahn, D.
    Miller, A. L.
    Velligan, D. I.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 586 - 587
  • [7] Tailored Interventions to Improve Medication Adherence for Cardiovascular Diseases
    Xu, Hai-Yan
    Yu, Yong-Ju
    Zhang, Qian-Hui
    Hu, Hou-Yuan
    Li, Min
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [8] Environmental supports improve targeted behaviors in schizophrenia
    Woolsey, M
    Wang, M
    Maples, NJ
    DiCocco, M
    Velligan, DI
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 536 - 536
  • [9] Schizophrenia and antipsychotic medication - Better adherence, better outcomes?
    Staring, A. B. P.
    Van der Gaag, M.
    Mulder, C. L.
    [J]. SCHIZOPHRENIA RESEARCH, 2013, 151 (1-3) : 296 - 297
  • [10] Interventions to Improve Medication Adherence in People with Schizophrenia: A Systematic Review
    Cahaya, Noor
    Kristina, Susi Ari
    Widayanti, Anna Wahyuni
    Green, James
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 2431 - 2449